<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF"><gtr:id>37DE1B14-06DD-4E06-AAC5-56F5BBED7FFF</gtr:id><gtr:name>MRC Toxicology Unit</gtr:name><gtr:address><gtr:line1>Hodgkin Building</gtr:line1><gtr:line2>University of Leicester</gtr:line2><gtr:line3>PO Box 138,  Lancaster Road</gtr:line3><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 9HN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8E5835D0-9D83-47CE-81A0-49EB6558C68F"><gtr:id>8E5835D0-9D83-47CE-81A0-49EB6558C68F</gtr:id><gtr:firstName>Michal</gtr:firstName><gtr:surname>Malewicz</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_A600_1109"><gtr:id>9A50FDFE-DACF-4067-94B4-F5172D90748E</gtr:id><gtr:title>Toxicity and the DNA-damage response.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_A600_1109</gtr:grantReference><gtr:abstractText>High?energy radiation (either environmental or used in clinical practice) produces toxic responses in human body. As the main consequence of radiation exposure is cellular DNA damage, we are aiming to understand how mammalian cells deal with the damage to its DNA. 
We are studying a group of proteins acting together in one DNA repair pathway ? the non-homologous end joining (NHEJ). This pathway is responsible for the majority of DNA repair in cells. We have managed to identify several new proteins functioning in this pathway (XLS/PAXX factor and NR4A nuclear receptors). Currently our work focuses on the question of how these new factors operate at the molecular level in the DNA repair process. We also continuously search for novel components of cellular DNA repair machinery.
We believe that these findings will facilitate approaches to manage toxic outcomes after radiation exposure.</gtr:abstractText><gtr:technicalSummary>Exposure to high-energy radiation can lead to severe toxic DNA damage in cells (for example by generating double strand DNA breaks). If not promptly repaired DNA damage can result in the accumulation of deleterious alterations to chromosomes and as a consequence produce various toxic outcomes, such as acute cell death. 
We are developing a Toxicology platform for studying toxic effects of agents that cause DNA damage in cells (MIE ? molecular initiating event). Examples of such toxic agents include ionizing radiation (e.g. X-rays) and radiotherapy.
Our unique approach uses proteome-wide analysis of DNA repair complexes for identification of crucial mediators governing toxic outcomes to DNA damage.
We are primarily interested in identifying proteins regulating cellular radiosensitivity. We believe that a radiosensitive phenotype typically identifies a key mediator of cellular response to DNA damage. Thus measuring a single parameter we are able to pinpoint some key regulatory components in cellular DNA damage response.
The final element of our Toxicology platform is the in-depth mechanistic study aimed at understanding in molecular terms the function of proteins identified in our proteomic screens. Currently we focus mostly on defining the function of XLS/PAXX protein and NR4A nuclear orphan receptors in double-strand DNA break repair. We are using a variety of genetic and biochemical approaches based on mammalian cell culture and rodent animal models.
Our goal is to provide new insights into the complex process of toxic DNA damage response, such that would increase our understanding of toxic outcomes after radiation exposure.</gtr:technicalSummary><gtr:fund><gtr:end>2018-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-16</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2384859</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Research Grant</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:fundingRef>RG120586</gtr:fundingRef><gtr:id>C29345DF-A48B-42E3-A7B4-7DDD6261BC5B</gtr:id><gtr:outcomeId>Z7j2eYkRZB4</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B7F74FC7-F7EB-491A-94C3-06FB8098CE53</gtr:id><gtr:title>Function of transcription factors at DNA lesions in DNA repair.</gtr:title><gtr:parentPublicationTitle>Experimental cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a5a91903248111eda494b5a5ddfbc73"><gtr:id>1a5a91903248111eda494b5a5ddfbc73</gtr:id><gtr:otherNames>Malewicz M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-4827</gtr:issn><gtr:outcomeId>5461e0b15ac2c0.59680299</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83CB132F-B5FC-42B5-9BF5-68C8C2031019</gtr:id><gtr:title>Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f446e86d6836d8e6a5da49dfe563b87"><gtr:id>8f446e86d6836d8e6a5da49dfe563b87</gtr:id><gtr:otherNames>Galluzzi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>5a7860d7b714d0.71807886</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9B0B094-4094-475D-8B83-9C726005B3BE</gtr:id><gtr:title>ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffdd89ae07415943d2b13fc500f29bf6"><gtr:id>ffdd89ae07415943d2b13fc500f29bf6</gtr:id><gtr:otherNames>Pieraccioli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>56d571777dfd85.98554112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>813FB925-2988-4A10-BF7B-A4DF75618D6F</gtr:id><gtr:title>XLS (c9orf142) is a new component of mammalian DNA double-stranded break repair.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67f1b69c978cedf569c15eb799a7c4df"><gtr:id>67f1b69c978cedf569c15eb799a7c4df</gtr:id><gtr:otherNames>Craxton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>56d57177ae4505.65603446</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B25789A-DED7-46E4-A3EB-3683871FBF30</gtr:id><gtr:title>The role of 53BP1 protein in homology-directed DNA repair: things get a bit complicated.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a5a91903248111eda494b5a5ddfbc73"><gtr:id>1a5a91903248111eda494b5a5ddfbc73</gtr:id><gtr:otherNames>Malewicz M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>58b483d5e7b162.68751300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84F67180-64E9-43D0-8891-F8111A72E712</gtr:id><gtr:title>Zinc-finger proteins in health and disease.</gtr:title><gtr:parentPublicationTitle>Cell death discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9743f96eb4529ca1797ecb6b3d8c25d"><gtr:id>e9743f96eb4529ca1797ecb6b3d8c25d</gtr:id><gtr:otherNames>Cassandri M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2058-7716</gtr:issn><gtr:outcomeId>5a7860bcd4e909.79110744</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>728D6632-DB75-4DB8-A372-1FB002B23075</gtr:id><gtr:title>New factors in mammalian DNA repair-the chromatin connection.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e144e85f6b35b0b47ad70427c196bab"><gtr:id>4e144e85f6b35b0b47ad70427c196bab</gtr:id><gtr:otherNames>Raschell? G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>5a78608a12f5f7.06929838</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_A600_1109</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>